Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy

J Antimicrob Chemother. 2017 Sep 1;72(9):2678-2679. doi: 10.1093/jac/dkx172.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / pharmacology
  • Cephalosporins / administration & dosage*
  • Drug Resistance, Multiple, Bacterial
  • Fractures, Bone / complications*
  • Fractures, Bone / surgery
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Osteomyelitis / drug therapy*
  • Penicillanic Acid / administration & dosage
  • Penicillanic Acid / analogs & derivatives*
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / isolation & purification
  • Tazobactam
  • Treatment Outcome
  • beta-Lactamase Inhibitors / administration & dosage*

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • beta-Lactamase Inhibitors
  • ceftolozane, tazobactam drug combination
  • Penicillanic Acid
  • Tazobactam